Clinical trials
Withdrawn Phase 3 trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| The University of Queensland | 2 |
| AbbVie | 1 |
| Applied Therapeutics, Inc. | 1 |
| Boehringer Ingelheim | 1 |
| Centocor, Inc. | 1 |
| Murdoch Childrens Research Institute | 1 |
| United Therapeutics | 1 |
| Xenova Biomedix | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 2 |
| Recurrence | 2 |
| Brain Neoplasms | 1 |
| COVID-19 | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Crohn Disease | 1 |
| Giant Cell Arteritis | 1 |
| Glioblastoma | 1 |
| Hepatitis C, Chronic | 1 |
| Hypertension, Pulmonary | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.